Home » Topics » Regulatory » Patents

Patents
RSS

Cell adhesion inhibitors developed by Sumitomo researchers

Oct. 2, 1998

MMP inhibitors from Bayer particularly useful for osteoarthritis and tumor metastasis

Oct. 2, 1998

Ono describes new prostanoid receptor ligands

Oct. 2, 1998

Potent analgesic agents from HMR with additional pharmacological effects

Oct. 2, 1998

ADIR claims 2-aminoindanes for CNS disorders involving serotonergic system dysfunction

Oct. 2, 1998

Progesterone antagonists claimed for cancer, gynecological disorders by Meiji Seika

Oct. 1, 1998

Agents for dementia a focus of R&D at Sanofi

Oct. 1, 1998

Peptides that bind to MHC class II proteins in development at Zeneca

Oct. 1, 1998

Selectin inhibitors described by Sanwa Kagaku for inflammatory disorders

Oct. 1, 1998

Neurogen compounds interacting with CRF1 receptors for stress-related disorders

Oct. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.